(VIANEWS) – The NASDAQ opens in less than five hours and Novavax‘s pre-market value is already 15.45% down.
The last session, NASDAQ Composite ended with Novavax (NVAX) falling 3.43% to $160.55. NASDAQ Composite rose 0.71% to $15,129.09, after five consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session.
Today’s last reported volume for Novavax is 2962992, 41.02% below its average volume of 5024323.
Novavax’s last close was $166.25, 49.88% under its 52-week high of $331.68.
The company’s growth estimates for the ongoing quarter is a negative 21.8% and positive 213.7% for the next.
Year-on-year quarterly revenue growth grew by 738.6%, now sitting on 1.18B for the twelve trailing months.
Novavax’s Stock Yearly Top and Bottom Value
Novavax’s stock is valued at $160.55 at 05:18 EST, way under its 52-week high of $331.68 and way higher than its 52-week low of $76.59.
Novavax’s Moving Average
Novavax’s value is way below its 50-day moving average of $214.39 and way under its 200-day moving average of $199.10.
Novavax’s last day, last week, and last month’s current volatility was 2.66%, 2.55%, and 5.07%, respectively.
Novavax’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 4.57% (day), 4.97% (last week), and 7.70% (last month), respectively.
More news about Novavax (NVAX).